A multipotent stromal cell with strong immunomodulatory and paracrine activity, the most studied cell type in regenerative medicine.
MSCs are the workhorse of modern regenerative medicine — they appear in nearly half of all active clinical trials. At a clinic, you'll hear 'placental MSCs' (from amniotic membrane, allogeneic), 'adipose-derived MSCs' (your own fat, autologous), or 'bone-marrow MSCs' (similarly autologous). The key difference: where they come from, not what they can do.
StemCellAtlas is your guide to stem-cell therapy: what the evidence shows, which conditions are treated, and the real all-in cost by country — typically €3,000–8,000 with our partner Stem Plus (Sofia), Europe's lowest-cost EU destination, versus $15,000–35,000 in the US.
Get an honest assessment